New Guidance and Forms for Consent for Systemic Anti-Cancer Therapy

The Chemotherapy Board, with support from Cancer Research UK, has published guidance on consent for Systemic Anti-Cancer Therapy (SACT). The guidance is accompanied by national SACT site – and regimen-specific consent forms. The guidance and forms – available on the Cancer Research UK website – are intended to support clinicians in ensuring that patients receiving SACT are fully informed when consenting to treatment. 

To view the new consent forms, click here.

Latest News

By BOPA committee on 10th July 2025

Update to BOPA Standards – New Guidance on Pharmacy Technician SACT Verification (Section 3.3)

Dear BOPA Members, We are pleased to share an important update to the BOPA Standards for the Pharmacy Verification of Prescriptions for Cancer Medicines (Version 5.0, 3 June 2025). A…

Read article
By Joseph Williams on 4th July 2025

Pharmacists’ Essential Guide to Haematology Course – 15th–16th September 2025 at UCLH

We’re excited to announce the next Pharmacists’ Essential Guide to Haematology course, hosted by the UCLH Cancer Academy. This two-day course is designed specifically for pharmacists starting their haem-oncology journey,…

Read article
By BOPA Research committee on 26th June 2025

SURVEY deadline extended – The use and development of ChemoCare Electronic Prescribing System for systemic anti-cancer therapy

Dear Oncology/Haematology Pharmacist, You are invited to participate in a survey exploring the factors that influence UK-registered pharmacists’ use and the development of ChemoCare Electronic Prescribing system (EPS) for systemic…

Read article
By BOPA Committee on 26th June 2025

“Cancer Basics” videos by Elaine Vickers available free on Youtube

Elaine Vickers, PhD, creator of the UTIC course, has also produced a playlist of ten short videos on “Cancer Basics”, which is freely available on YouTube. In these videos, Elaine…

Read article